These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 24104553)

  • 21. IL-37 suppresses hepatocellular carcinoma growth by converting pSmad3 signaling from JNK/pSmad3L/c-Myc oncogenic signaling to pSmad3C/P21 tumor-suppressive signaling.
    Liu R; Tang C; Shen A; Luo H; Wei X; Zheng D; Sun C; Li Z; Zhu D; Li T; Wu Z
    Oncotarget; 2016 Dec; 7(51):85079-85096. PubMed ID: 27835881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of c-myc mRNA in hepatocellular carcinomas, noncancerous livers, and normal livers.
    Ikeguchi M; Hirooka Y
    Pathobiology; 2004; 71(5):281-6. PubMed ID: 15459488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells.
    Tai CJ; Chin-Sheng H; Kuo LJ; Wei PL; Lu HH; Chen HA; Liu TZ; Liu JJ; Liu DZ; Ho YS; Wu CH; Chang YJ
    Ann Surg Oncol; 2012 Jan; 19(1):336-43. PubMed ID: 21516372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
    Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stanniocalcin-1 Reduces Tumor Size in Human Hepatocellular Carcinoma.
    Yeung BH; Shek FH; Lee NP; Wong CK
    PLoS One; 2015; 10(10):e0139977. PubMed ID: 26469082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
    Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
    Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B virus X protein upregulates Lin28A/Lin28B through Sp-1/c-Myc to enhance the proliferation of hepatoma cells.
    You X; Liu F; Zhang T; Lv N; Liu Q; Shan C; Du Y; Kong G; Wang T; Ye L; Zhang X
    Oncogene; 2014 Jan; 33(4):449-60. PubMed ID: 23318446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma.
    Li L; Jin R; Zhang X; Lv F; Liu L; Liu D; Liu K; Li N; Chen D
    Hepatology; 2012 Oct; 56(4):1380-90. PubMed ID: 22706665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CYLD: a deubiquitination enzyme with multiple roles in cancer.
    Massoumi R
    Future Oncol; 2011 Feb; 7(2):285-97. PubMed ID: 21345146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
    Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K
    J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. JNK1, JNK2, and JNK3 are involved in P-glycoprotein-mediated multidrug resistance of hepatocellular carcinoma cells.
    Yan F; Wang XM; Liu ZC; Pan C; Yuan SB; Ma QM
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):287-95. PubMed ID: 20525557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer.
    Luo ZG; Tang H; Li B; Zhu Z; Ni CR; Zhu MH
    Oncol Rep; 2011 Apr; 25(4):1073-81. PubMed ID: 21286670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of the putative oncogene COTE1 contributes to human hepatocarcinogenesis through modulation of WWOX signaling.
    Zhang H; Tian Y; Shen J; Wang Y; Xu Y; Wang Y; Han Z; Li X
    Int J Oncol; 2014 Aug; 45(2):719-31. PubMed ID: 24899407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation.
    Hui L; Zatloukal K; Scheuch H; Stepniak E; Wagner EF
    J Clin Invest; 2008 Dec; 118(12):3943-53. PubMed ID: 19033664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
    Ritorto MS; Borlak J
    J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTTG1 is involved in TNF-α-related hepatocellular carcinoma via the induction of c-myc.
    Lin X; Yang Y; Guo Y; Liu H; Jiang J; Zheng F; Wu B
    Cancer Med; 2019 Sep; 8(12):5702-5715. PubMed ID: 31385458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.
    Wang H; Lai Y; Mathis BJ; Wang W; Li S; Qu C; Li B; Shao L; Song H; Janicki JS; Sun SC; Wang XL; Tang D; Cui T
    J Mol Cell Cardiol; 2015 Jul; 84():143-53. PubMed ID: 25935309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the GNMT-HectH9-PREX2 tripartite relationship in the pathogenesis of hepatocellular carcinoma.
    Li CH; Yen CH; Chen YF; Lee KJ; Fang CC; Zhang X; Lai CC; Huang SF; Lin HK; Arthur Chen YM
    Int J Cancer; 2017 May; 140(10):2284-2297. PubMed ID: 28205209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis.
    Bai HY; Liao YJ; Cai MY; Ma NF; Zhang Q; Chen JW; Zhang JX; Wang FW; Wang CY; Chen WH; Jin XH; Xu RH; Guan XY; Xie D
    Stem Cells; 2018 Feb; 36(2):180-191. PubMed ID: 29119708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.